C-Path

Foundation date

29/01/2021

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

Founded in 2021, C-Path, or Connected-Pathology, provides a full suite of preclinical and clinical pathology solutions. These include conventional pathology, molecular pathology, laboratory animal pathology, and preclinical safety and efficacy, as well as clinical consulting, AI pathology, digital sample tracking, and data management. C-Path puts a particular focus on the digitalization of pathology as a companion to expertise, and as a means to save the precious time of pathologists for where their expertise matters.

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    7 hours ago

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022